SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-170592
Filing Date
2020-06-17
Accepted
2020-06-16 18:41:43
Documents
13
Period of Report
2020-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d944550d8k.htm   iXBRL 8-K 42694
2 EX-10.1 d944550dex101.htm EX-10.1 813655
  Complete submission text file 0001193125-20-170592.txt   1182262

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA myl-20200616.xsd EX-101.SCH 3058
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE myl-20200616_lab.xml EX-101.LAB 19549
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myl-20200616_pre.xml EX-101.PRE 12269
13 EXTRACTED XBRL INSTANCE DOCUMENT d944550d8k_htm.xml XML 3576
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-199861 | Film No.: 20967634
SIC: 2834 Pharmaceutical Preparations